相关实验视频
Updated: Jul 15, 2025

Murine Fecal Isolation and Microbiota Transplantation
Published on: May 26, 2023
变化的肠道微生物群和代谢在患有异常性膜性脏病患者
Xiaohu Shi1, Zhaojun Li2, Weifeng Lin3
1Department of Traditional Chinese Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
异形膜性脏病 (IMN) 患者表现出肠道失生症,与改变的微生物群落和降低的酸盐代谢. 这些发现表明IMN诊断和治疗的潜在的微生物向生物标志物.
科学领域:
- 微生物学 微生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢学 代谢学 代谢学
背景情况:
- 肠道微生物组失调与慢性病有关,但其在异常性膜性病 (IMN) 中的作用尚不清楚.
- 了解肠道微生物群对IMN病变的影响,对于开发新的治疗策略至关重要.
研究的目的:
- 调查中国IMN患者肠道细菌和便代谢物的变异.
- 探索肠道微生物群和IMN临床特征之间的相关性.
- 为了确定IMN诊断的潜在的基于微生物群的生物标志物.
主要方法:
- 16S rRNA基因测序分析了41名IMN患者和41名健康对照 (HC) 的微生物群落.
- "Tax4Fun"预测了功能特征,而非向的代谢学分析了便代谢物.
- 相关性分析探讨了肠道细菌和IMN临床参数之间的关系.
主要成果:
- 与HC相比,IMN患者的微生物丰富性和多样性降低,与HC相比,有显著的分类学和功能失调.
- 特定的属,如Citrobacter和Akkermansia与临床参数相关.
- 使用20种微生物生物标志物的预测模型实现了93.53%的诊断准确度;观察到托代谢减少,但尿素毒素并不突出.
结论:
- 肠道微生物群的变化有助于IMN的发病.
- 针对微生物群的生物标志物为IMN诊断和治疗提供了一个有希望的途径.
- 肠道功能失调可能会增加肠道的透性,并激活脏的NOD类受体.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Nephrotic Syndrome I : Introduction
Fungal Phylum Microsporidia
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Nephrotic Syndrome III : Nursing Management